History of Evomed

 

Evomed MedizinService GmbH is founded as a spin-off of the Darmstadt-based company R-Biopharm AG

Launch of the ImuPro300 blood test, which can detect delayed food allergies (type III)

Cooperation with Leipzig-based company INDAGO GmbH, particularly in the area of metabolism diagnostics.

First cooperation between Ralf Schierl (Evomed) and Dr. Johannes Coy (cancer researcher and discoverer of the TKTL1 metabolic pathway) in the area of tumour diagnostics and treatment: Distribution of the first TAVARLIN foods (oils, breads and lactate drink)

Cooperation with the InVitaLab GmbH laboratory in Neuss

Foundation of the TAVARLIN AG company, whose main focus is based on the practical consequences of the discovery of the TKTL1-enzyme by Dr. Johannes Coy

Introduction of the ImuPro100Plus "module system"

Launch of the EDIM-TKTL1 blood test, which uses the TKTL1-enzyme discovered by Dr. Coy, for the detection of the particularly aggressive TKTL1-positive cancer cells.